OV Solve 2.5mg Tablet

Description

Information About OV Solve 2.5mg Tablet.

The medicine is specifically for women with postmenopausal breast cancer. Healthcare professionals may recommend OV Solve 2.5mg Tablet alone or with other medications depending on the stage of the tumour. Letrozole is the main component of the medication. 

OV Solve 2.5mg Tablet Uses

In the treatment of  OV Solve 2.5mg Tablet

OV Solve 2.5mg Tablet Benefits

• Breast cancer cells thrive in the presence of estrogen (natural female hormone). 
• OV Solve 2.5mg Tablet, being an aromatase inhibitor, reduces the production of estrogen. 
• It stops or at least slows down the growth of the cancer.

How to Use an OV Solve 2.5mg Tablet?

Swallow the tablet as a whole with a glass of water, and do not crush or break it before consumption. Chewing the tablet is not recommended. Take it before, after, or during your meals, but maintain a fixed time of the dosage. Do not increase or decrease your dose without the doctor’s permission. 

OV Solve 2.5mg Tablet Side Effects.

There are a number of side effects of taking this medicine, which you should be aware of. Take note of the following adverse consequences of using OV Solve 2.5mg Tab. 

• Nausea
• Dizziness
• Weakness
• Cough
• Tiredness
• Night sweats
• Swelling
• Short Breath
• Gain in weight
• Hot flushes
• Flushing in the face, ears, neck, and trunk
• High Level of Cholesterol in the body
• Fracture in the bones
• Pain in the bones
• Osteoporosis
• Diaphoresis
• Joint pain
• Pain the Back
• Inflammation in the joints

In case these side effects trouble you a lot, get in touch with your medical advisor for a solution. 

Caution 

• Pregnant and breastfeeding women must not take this medicine for their and their children’s safety. 
• Liver patients should ask their medical advisor if it is safe to take this medicine in such conditions. 
• Driving can be unsafe after a dose because the medicine causes dizziness, and you may have trouble concentrating. 

Frequently Asked Question (FAQs)

Q1. What is the salt composition of OV Solve 2.5mg Tablet?

The medicine is composed of an ingredient called Letrozole, which is a nonsteroidal aromatase inhibitor.

Q2. Is OV Solve 2.5mg Tab safe during pregnancy?

No. The medication is not safe for pregnant and breastfeeding ladies.  

Q3. I have a liver infection. Can I use an OV Solve 2.5mg Tab?

The liver patient should ask their doctors about the safety of this medicine as it can be harmful to their organs. 

Q4. Can I drive after taking a dose of OV Solve 2.5mg Tab?

No. The medicine may affect your ability to concentrate, so try to avoid driving after taking a dose.  

Q5. Can OV Solve 2.5mg Tab cause heavy sweating?

Yes. One of the rare side effects of using OV Solve 2.5mg Tab is heavy sweating.  

References

• Moy B, Lee RJ, Smith M. Natural Products in Cancer Chemotherapy: Hormones and Related Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1762.
• Letrozole. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 1997 [revised Jan. 2014]. [Accessed 03 Apr. 2019] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020726s027lbl.pdf 
• Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 718.
• Letrozole [Prescribing Information]. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2020. [Accessed 08 Jul. 2023]. (online) Available from: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=82b77d74-085f-45ac-a7dd-1f5c038bf406&type=display# 
• National Health Service. Letrozole. [Last Reviewed: 21 Jul 2020]. [Accessed 08 Jul. 2023]. (online) Available from: https://www.nhs.uk/medicines/letrozole/ 
• Letrozole [Package Insert]. Mumbai, India: HOPE Lifecare. [Accessed 08 Jul. 2023]. (online) Available from: https://5.imimg.com/data5/JI/VD/UC/SELLER-81155248/letrozole.pdf 
• Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 786-87.
• Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from: https://cdscoonline.gov.in/CDSCO/Drugs

Marketer details

Name: D.S. Lab

Address: Plot No E 1/2, Zone-B, Industrial Estate, Bolangir 767001, Orissa.

Country of origin: India
Expires on or after: January, 2025

Vendors:

The responsibility of delivering your medicine falls on our partner vendor, who is licensed and is nearest to you. You will receive the details of the pharmacy after they accept the order. They will only accept the order if they have the medicine and if the doctor’s ℞ in your prescription is valid